WDC
66
-2
ABT
30
-3
PNR
30
-2
MHK
27
-3
GLW
82
3
GS
62
3
REGN
53
-3
CNX
48
4
EOG
62
6
MAC
53
2
AMGN
39
-5
WM
80
6
MAS
34
-4
EBAY
56
3
O
48
-14
NRG
45
3
SYY
31
-4
LOW
24
-4
DG
57
7
RRC
70
12
WDC
66
-2
ABT
30
-3
PNR
30
-2
MHK
27
-3
GLW
82
3
GS
62
3
REGN
53
-3
CNX
48
4
EOG
62
6
MAC
53
2
AMGN
39
-5
WM
80
6
MAS
34
-4
EBAY
56
3
O
48
-14
NRG
45
3
SYY
31
-4
LOW
24
-4
DG
57
7
RRC
70
12
Financhill
Back

iShares Broad USD Investment Grade Corporate Bond Vs. Apogee Therapeutics, Inc. Industry Stock Comparison

Sell
42

USIG
iShares Broad USD Investment Grade Corporate Bond

Last Price:
$51.22
Seasonality Move:
0.42%
Sell
44

APGE
Apogee Therapeutics, Inc.

Last Price:
$84.40
Seasonality Move:
-11.77%
Sell
42
iShares Broad USD Investment Grade Corporate Bond (USIG) is a Sell

Is iShares Broad USD Investment Grade Corporate Bond a Buy, Sell or Hold?

  • The current iShares Broad USD Investment Grade Corporate Bond [USIG] share price is $51.21. The Score for USIG is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • USIG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Apogee Therapeutics, Inc. (APGE) is a Sell

Is Apogee Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Apogee Therapeutics, Inc. [APGE] share price is $84.34. The Score for APGE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • APGE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

USIG Stock Price Chart

What is iShares Broad USD Investment Grade Corporate Bond's stock price today?

  • The iShares Broad USD Investment Grade Corporate Bond share price today is $51.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and USIG is experiencing buying pressure, which is a positive indicator for future bullish movement.

APGE Stock Price Chart

What is Apogee Therapeutics, Inc.'s stock price today?

  • The Apogee Therapeutics, Inc. share price today is $84.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APGE is experiencing buying pressure, which is a positive indicator for future bullish movement.

USIG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 47.34 Sell
Chaikin Money Flow: 1268248 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.91 - 51.79) Sell
Bollinger Bands (100): (51.44 - 52.2) Sell

APGE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.18 Buy
Relative Strength Index (14 RSI): 64.96 Buy
Chaikin Money Flow: 432550 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (69.1 - 79.44) Buy
Bollinger Bands (100): (66.23 - 78.47) Buy

USIG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.01 Buy
20-day SMA: 51.18 Buy
50-day SMA: 51.71 Sell
200-day SMA: 51.78 Sell
8-day EMA: 51.08 Buy
20-day EMA: 51.24 Sell
50-day EMA: 51.55 Sell
200-day EMA: 51.64 Sell

APGE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 79.91 Buy
20-day SMA: 75.21 Buy
50-day SMA: 71.36 Buy
200-day SMA: 57.28 Buy
8-day EMA: 80.37 Buy
20-day EMA: 76.41 Buy
50-day EMA: 73.33 Buy
200-day EMA: 61.58 Buy

iShares Broad USD Investment Grade Corporate Bond Earnings Growth & USIG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apogee Therapeutics, Inc. Earnings Growth & APGE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.62 per share.

iShares Broad USD Investment Grade Corporate Bond Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apogee Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):